Global Monoclonal Antibody Service Market Growth (Status and Outlook) 2024-2030

Global Monoclonal Antibody Service Market Growth (Status and Outlook) 2024-2030

Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.

The global Monoclonal Antibody Service market size is projected to grow from US$ 6932.6 million in 2023 to US$ 8531.1 million in 2030; it is expected to grow at a CAGR of 3.0% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Monoclonal Antibody Service Industry Forecast” looks at past sales and reviews total world Monoclonal Antibody Service sales in 2023, providing a comprehensive analysis by region and market sector of projected Monoclonal Antibody Service sales for 2024 through 2030. With Monoclonal Antibody Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monoclonal Antibody Service industry.

This Insight Report provides a comprehensive analysis of the global Monoclonal Antibody Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monoclonal Antibody Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Monoclonal Antibody Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monoclonal Antibody Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monoclonal Antibody Service.

Thermo Fisher ranks the first in terms of revenue share in global market of Antibody Services, occupies 18% of the global market share. While, Covance, with a market share of 14%, comes the second. All the other manufacturers which are not included in the report together consist of approximately 46% of the global market.

North America ranks the top in terms of market size of Antibody Services, which alone consists of 40% of the global market. Europe comes the second, with 31% of the global market. Asia Pacific ranks the third, consists of about 18% of the global antibody service market in the same year. All the other regions combined occupy only 8% of the global Antibody Service market.

This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibody Service market by product type, application, key players and key regions and countries.

Segmentation by type
Reagents
Drugs
Other

Segmentation by application
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Roche
Eli Lilly
Bayer
Amgen
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Merck
Abbott Laboratories
GSK
BMS
Alexion
UCB
Seattle Genetics

Please note: The report will take approximately 2 business days to prepare and deliver.